High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome

Journal of Electrocardiology

Volumn 44, Issue 4, 2011, Pages 483-486

  Zhang, Li Ping ^a   Hui, Bin ^b   Gao, Bing Ren ^a  

^a LANZHOU UNIVERSITY   (China)

^b JIAXING UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Genetics; Sudden cardiac death; Wolff Parkinson White syndrome

Indexed keywords

AMIODARONE; PROTEIN KINASE; PROTEIN PRKAG2; UNCLASSIFIED DRUG;

ABLATION THERAPY; ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; ELECTROCARDIOGRAM; FEMALE; GENETIC ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACEMAKER; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HUMAN; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SUDDEN DEATH; TACHYCARDIA; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VITAL SIGN; WOLFF PARKINSON WHITE SYNDROME;

AMP-ACTIVATED PROTEIN KINASES; CHINA; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; WOLFF-PARKINSON-WHITE SYNDROME; YOUNG ADULT;

EID: 79959731727     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2010.02.009     Document Type: Conference Paper

References (15)

1. Wan Q., Wu N., and Fan W. Clinical manifestations and prevalence of different types of supraventricular tachycardia among Chinese Chin Med J (Engl) 105 1992 284
2. Gollob M.H., Green M.S., and Tang A.S. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome N Engl J Med 344 2001 1823
3. Sidhu J., and Roberts R. Genetic basis and pathogenesis of familial WPW syndrome Indian Pacing Electrophysiol J 3 2003 197
4. Lalani S.R., Thakuria J.V., and Cox G.F. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits J Med Genet 46 2009 168
5. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control Trends Biochem Sci 29 2004 18
6. Burwinkel B., Scott J.W., and Buhrer C. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency Am J Hum Genet 76 2005 1034
7. Gollob M.H., Green M.S., and Tang A.S. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy Curr Opin Cardiol 17 2002 229
8. Gollob M.H., Seger J.J., and Gollob T.N. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy Circulation 104 2001 3030
9. Light P.E., Wallace C.H.R., and Dyck J.R.B. Constitutively-active AMP-activated protein kinase regulates voltage-gated sodium channels in ventricular myocytes Circulation 107 2003 1962
10. Pappone C., Radinovic A., and Santinelli V. Sudden death and ventricular preexcitation: is it necessary to treat the asymptomatic patients? Curr Pharm Des 14 2008 762
11. Fitzsimmons P.J., and Mc Whirter P.D. The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years Am Heart J 142 2001 530
12. Basso C., Corrado D., and Rossi L. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death Circulation 103 2001 269
13. Gollob M.H. Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome Biochem Soc Trans 31 2003 228
14. Wolf C.M., Arad M., and Ahmad F. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations Circulation 117 2008 144
15. Sanbe A., Gulick J., and Hanks M.C. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter Circ Res 92 2003 609